new oral antiviral for chronic hepatitis B called Baraclude (entecavir)
October 2006
Health Canada has approved a new oral antiviral for chronic hepatitis B called Baraclude (entecavir).
It will be used as an alternative to Intron A (interferon alfa-2b)...Heptovir (lamivudine)...or Hepsera (adefovir).
Intron A is effective for suppressing the hepatitis B virus and requires a shorter treatment duration than the oral antivirals.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote